Novartis AG ADR (NVS)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $303.12B
Last updated: Nov 17, 2026 at 4:33 PM ET
Novartis AG ADR (NVS) Statistics
Novartis AG ADR (NVS) has a market cap of $303.12B and an enterprise value of $340.60B. Its trailing P/E is 18.6x.
Total Valuation
Enterprise value is 12.36% above the market cap, as debt exceeds cash.
| Market Cap | $303.12B |
|---|---|
| Enterprise Value | $340.60B |
| Latest price (Nov 17, 2026) | $159.16 |
Key Dates
The last ex-dividend date was Mar 11, 2026.
| Last Earnings Date | Oct 27, 2026 |
|---|---|
| Last Ex-Dividend Date | Mar 11, 2026 |
| Last Payment Date | Mar 16, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 5.4x and 8.1x. Its year-end P/E ranged from 12.5x to 17.9x from 2016 to 2025.
| P/E Ratio | 18.6x |
|---|---|
| Forward P/E | 17.8x |
| P/S Ratio | 5.4x |
| Forward P/S | 5.2x |
| P/B Ratio | 8.1x |
| P/FCF Ratio | 20.4x |
| P/OCF Ratio | 17.5x |
| PEG Ratio | 2.4 |
Enterprise Valuation
Counting debt and cash, the company is valued at 15.6x EBITDA and 23.0x free cash flow.
| EV / Earnings | 33.9x |
|---|---|
| EV / Sales | 6.0x |
| EV / EBITDA | 15.6x |
| EV / EBIT | 23.9x |
| EV / FCF | 23.0x |
Price Statistics
The stock is up 24.97% over 52 weeks and trades 6.41% above its 50-day average.
| Beta (1Y) | 0.35 |
|---|---|
| 52-Week Change | +24.97% |
| 1-Month Change | +5.97% |
| 3-Month Change | -0.72% |
| 6-Month Change | +5.80% |
| 5-Year Change | +94.28% |
| 10-Year Change | +126.40% |
| Total Return (1Y) | +28.72% |
| Total Return (3Y CAGR) | +21.72% |
| Total Return (5Y CAGR) | +17.83% |
| Return vs SPY (1Y) | +16.58% |
| Max Drawdown (1Y) | -16.17% |
| Max Drawdown (3Y) | -19.95% |
| Sharpe Ratio (1Y) | 0.91 |
| Correlation with SPY (1Y) | 0.18 |
| 50-Day Average | $149.57 |
| 200-Day Average | $152.06 |
| 52-Week Range | $119.60 to $165.96 |
| RSI (14 Days) | 55.1 |
| Average Volume (20 Days) | 2.18M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.88x current liabilities, and total debt is 1.25x shareholder equity.
| Current Ratio | 0.88x |
|---|---|
| Quick Ratio | 0.70x |
| Debt / Equity | 1.25x |
| Debt / EBITDA | 2.13x |
| Debt / FCF | 3.12x |
| Interest Coverage | 9.02x |
Returns and Efficiency
Return on invested capital is 13.48% over the last 12 months, against a 5-year average of 15.10%.
| Return on Equity (ROE) | 26.95% |
|---|---|
| Return on Assets (ROA) | 8.56% |
| Return on Invested Capital (ROIC) | 13.48% |
| Return on Capital Employed (ROCE) | 16.81% |
| ROE (5Y Average) | 27.29% |
| ROA (5Y Average) | 12.66% |
| ROIC (5Y Average) | 15.10% |
| Asset Turnover | 0.50x |
| Inventory Turnover | 2.32x |
| Receivables Turnover | 5.68x |
| Cash Conversion Cycle | 113 days |
Taxes
Income tax took 20.80% of pretax income over the last 12 months.
| Income Tax (TTM) | $2.63B |
|---|---|
| Effective Tax Rate | 20.80% |
Scores
NVS has an Altman Z-Score of 3.60, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.60 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 8 of 9 |
| Piotroski Strength | Strong |
Income Statement
Revenue was $56.31B over the last 12 months.
| Revenue | $56.31B |
|---|---|
| Gross Profit | $42.02B |
| Operating Income | $14.33B |
| Pretax Income | $12.65B |
| Net Income | $10.03B |
| EBITDA | $21.78B |
| EBIT | $14.22B |
| Reported EPS (TTM) | $8.55 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 31.78% of the $117.15B in total assets.
| Cash and Equivalents | $8.87B |
|---|---|
| Total Debt | $46.35B |
| Net Debt | $37.48B |
| Working Capital | -$3.78B |
| Shareholder Equity | $37.23B |
| Tangible Book Value | -$29.77B |
| Total Assets | $117.15B |
| Total Liabilities | $79.58B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $2.48B of capital spending, operating cash flow left $14.84B of free cash flow.
| Operating Cash Flow | $17.32B |
|---|---|
| Capital Expenditures | $2.48B |
| Free Cash Flow | $14.84B |
| FCF Per Share | $7.86 |
| Depreciation and Amortization | $7.56B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 25.46%, against a 5-year average of 24.27%.
| Gross Margin | 74.62% |
|---|---|
| Operating Margin | 25.46% |
| Pretax Margin | 22.46% |
| Net Margin | 17.82% |
| EBITDA Margin | 38.69% |
| EBIT Margin | 25.26% |
| FCF Margin | 26.36% |
| Gross Margin (5Y Average) | 74.19% |
| Operating Margin (5Y Average) | 24.27% |
| Net Margin (5Y Average) | 30.04% |
Growth
Revenue grew 9.25% a year over 3 years, and EPS 13.63% a year.
| Revenue Growth (3Y CAGR) | +9.25% |
|---|---|
| Revenue Growth (5Y CAGR) | +2.58% |
| EPS Growth (3Y CAGR) | +13.63% |
| EPS Growth (5Y CAGR) | +9.21% |
| FCF Growth (3Y CAGR) | +15.02% |
| FCF Growth (5Y CAGR) | +9.72% |
| Operating Income Growth (3Y CAGR) | +30.46% |
Dividends and Yields
NVS pays out 52.50% of earnings as dividends.
| Dividend Per Share (Annual) | $4.77 |
|---|---|
| Dividend Yield | 3.00% |
| Payment Schedule | Annual |
| Dividend Growth (3Y CAGR) | +6.30% |
| Dividend Growth (5Y CAGR) | +5.28% |
| Payout Ratio | 52.50% |
| Earnings Yield | 5.38% |
| FCF Yield | 4.89% |
| Shareholder Yield | 3.00% |
Stock Splits
The last split was a 2-for-1 forward split on May 11, 2000.
| Last Split Date | May 11, 2000 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 9 similar companies, NVS has the 7th highest P/E.
P/E RatioPeer median 22.2x
P/S RatioPeer median 4.9x
ROICPeer median 13.95%
Dividend YieldPeer median 2.37%
| P/E Ratio | 18.6x vs 22.2x median |
|---|---|
| P/S Ratio | 5.4x vs 4.9x median |
| ROIC | 13.48% vs 13.95% median |
| Dividend Yield | 3.00% vs 2.37% median |
Analyst Forecast
Consensus estimates put revenue growth at 4.48% and EPS growth at 7.56% a year over the next 5 fiscal years.
| Revenue Growth Forecast (5Y CAGR) | +4.48% |
|---|---|
| EPS Growth Forecast (5Y CAGR) | +7.56% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NVS
What is NVS's market cap?
Novartis AG ADR has a market cap of $303.12B. Its enterprise value, which adds debt and subtracts cash, is $340.60B.
What is NVS's P/E ratio?
Novartis AG ADR has a trailing P/E ratio of 18.6x and a forward P/E of 17.8x.
How many shares of NVS are outstanding?
Novartis AG ADR has 1.91B shares outstanding. The count is down 1.80% from a year earlier.
Does NVS pay a dividend?
Yes. Novartis AG ADR pays $4.77 a share a year, a dividend yield of 3.00%.
How much debt does NVS have?
Novartis AG ADR has $46.35B of total debt and $8.87B of cash and equivalents, a net debt position of $37.48B.
NVS pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts